HC Wainwright & Co. analyst Joseph Pantginis downgrades Applied Genetic Techs (NASDAQ:AGTC) from Buy to Neutral.
What To Know About Jefferies’s Downgrade of TCR2 Therapeutics
Jefferies downgraded its rating of TCR2 Therapeutics (NASDAQ:TCRR) to Underperform with a price target of $3.00, changing its…